The Chemical Abstracts Service (CAS), a division of the American Chemical Society, announced it has released an open-access database of chemical compounds with known or potential antiviral properties to assist organizations with COVID‑19 research.
The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
Biotherapeutics company Viscient Biosciences said it, or a sister company to be funded and launched shortly using the same technology, will use 3D bioprinting technology to create lung tissue to support viral infectivity research and search for an effective therapy against SARS-CoV-2, the novel coronavirus which causes COVID-19.
Bruker is showcasing a number of its new analytical systems and other products for biopharma and forensics applications. The products include a new gas analyzer as well as a benchtop x-ray elemental analyzer.
Kleo Pharmaceuticals is joining forces with Green Cross LabCell of South Korea to advance testing of natural killer (NK) cell therapies as a potential treatment for COVID-19 patients.
Agilent Technologies has launched Vaya Raman, a handheld raw material identity verification system for pharmaceutical manufacturers.
Generation Bio and Vir Biotechnology have agreed to collaborate on research into the use of monoclonal antibodies against the SARS-CoV-2 virus that causes COVID-19.
Johnson & Johnson has selected a lead COVID-19 vaccine candidate from a number of options it has been working on since January. The company hopes to release a vaccine by 2021.
Charles River Laboratories has entered into a partnership with software firm Deciphex to offer a digital pathology workflow platform.
LabShares Newton is offering free, fully equipped biosafety level 2 lab space, facilities, and resources for researchers addressing the global COVID-19 pandemic, it announced on March 30.